BSEBoard Meeting6d ago · 29 Jul 2026, 02:36 pm
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Unaudited Financial ....
Gennex Laboratories Ltd · 531739
✦ AI SummaryResults
Gennex Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve the Unaudited Financial Statements for the Quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
Attachments (1)
📄pdf
Download →
cfb74261-d925-4aeb-96a2-87800b097750.pdf
View document text
Ref: GLL/SE/2026-27/July - ———y—eu can trust Date: 29/07/2026
To To
The General Manager, The Listing Manager,
Corporate Relations Department, The Ahmedabad Stock Exchange Limited
BSE Limited A-2, Kamdhenu Complex,
Phiroze Jeejeebhoy Towers, Opp. Sahajanand College,
Dalal Street, Mumbai - 400001. 120 Feet Ring Road, Panjara Pol, Ambawadi,
Maharashtra State, India. Ahmedabad - 380015.
Script Code: 531739 Gujarat State, India.
Script Code:
The Calcutta Stock Exchange Limited,
#7, Lyons Range, Murgighata,
Dalhousie, Kolkata - 700001,
West Bengal State, India.
Script Code: 26178
Dear Sir/Madam,
Sub: Intimation of Board Meeting to be held on Friday, August 14, 2026 of Gennex Laboratories
Limited
Ref: Regulation 29(1)(a), 33 and 47 of SEBI (LODR) Regulations, 2015
With reference to the above captioned subject matter, we hereby inform you that the Meeting of
Board of Directors of the Company will be held on Friday, August 14, 2026 at 04:00 PM at the
Corporate Office of the Company, inter-alia, to consider the following matters, among other items
of agenda:
1. Consider and adopt the Unaudited Financial Statements (Standalone and Consolidated) for
the Quarter ended June 30, 2026;
2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and
Consolidated Financial Statements for the Quarter ended June 30, 2026;
3. Other Business items.
Further, in continuation to earlier disclosure dated June 23, 2026, regarding the closure of trading
window w.e.f. July 01, 2026 in pursuant to SEBI (Prohibition of Insider Trading) Regulations,
2015, as amended, Trading Window for dealing in the securities of the Company shall open after
48 hours of declaration of Unaudited Financial Results for the quarter ended June 30, 2026 for
all designated persons, their immediate relatives and all connected persons covered under the
aforesaid code.
This intimation is also being uploaded on the Company website: www.gennexlab.com.
We request you to take the above information on record and acknowledge receipt of the same.
Thanking you,
Yours faithfully
For Gen boratories Limited
Dinesh Kumar Kejriwal “| a \R ‘
Company Secretary & Compliance Officer».
Membership #A19293 NG
Gennex Laboratories Limited
Akash Ganga, 4th Floor, Plot No.144, Srinagar Colony, Hyderabad-500073, Telangana State, India | Tel : +91-40-67334400 (30 Lines), 23746451
Factory : Sy.No.133, Bollaram Village, Jinnaram Mandal, Sangareddy Dist - 502 325, Telangana State, India. Tel : +91-08458 295516,
info@gennexlab.com, www.gennexlab.com ff CIN : L24230TG1990PLC011168